TAS120, a covalently-binding FGFR inhibitor (FGFRi), overcomes resistance to BGJ398 in patients with FGFR2 fusion positive cholangiocarcinoma Meeting Abstract
| Authors: | Goyal, L.; Liu, L. Y.; Lennerz, J. K.; Harding, J. J.; Huang, J.; Winkler, R.; Hiroshi, H.; Ting, D. T.; Juric, D.; Corcoran, R. B.; El-Bardeesy, N.; Zhu, A. X. |
| Abstract Title: | TAS120, a covalently-binding FGFR inhibitor (FGFRi), overcomes resistance to BGJ398 in patients with FGFR2 fusion positive cholangiocarcinoma |
| Meeting Title: | 109th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 78 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2018 Apr 14-18 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-07-01 |
| Language: | English |
| ACCESSION: | WOS:000468818900256 |
| DOI: | 10.1158/1538-7445.Am2018-lb-092 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LB-092 -- Source: Wos |
